Executives from Allen Institute, Benaroya Research Institute at Virginia Mason, FUJIFILM SonoSite, Bristol-Myers Squibb, Lyell Immunopharma, and Fenwick & West LLP.
SEATTLE–(BUSINESS WIRE)–Life Science Washington, the state’s life science trade association, announced the addition of three new board members in 2020, and new leadership on the Executive Committee.
Margaret McCormick, PhD, Executive Director and Chief Operating Officer, Benaroya Research Institute at Virginia Mason, and Vice President of Research for Virginia Mason Medical Center will serve as Board Chair for 2020-2022. She succeeds Caitlin Cameron, Chair and CEO of OtoNexus Medical Technologies, who will continue to serve on the Executive Committee.
Dr. McCormick has a lengthy and substantive relationship with Life Science Washington. She joined the Life Science Washington Board in 2007, was elected to the Executive Committee in 2008 and served as the Treasurer of the Association for 10 years. Additionally, she served on the Board of the Life Science Washington Institute from its inception in 2017 through June of 2019. She also brings decades of experience in the science and business of biotechnology research to her new role as Life Science Washington Board Chair.
Joining the Life Science Washington Executive Committee are Richard Fabian, President & COO, FUJIFILM SonoSite and Teresa Foy, PhD, Senior Vice President, Immunology-Oncology and Cellular Therapy, Bristol-Myers Squibb. Both currently serve on the Life Science Washington Board.
Newly elected Life Science Washington Directors are:
- Jan Beck, Head of R&D Operations, Lyell Immunopharma
- Lauren Hackett, MPA, Chief Operations Officer, Allen Institute
- Amanda Rose, Partner, Corporate, Fenwick & West LLP
“I am delighted to welcome more highly talented women to our board and to have additional medical device expertise on the Executive Committee.” said Dr. Leslie Alexandre, President & CEO of Life Science Washington. “Over the past three years, we have deliberately increased the representation of women on our Board from 15% to over 40%. We have also added more life science leaders from across the state and from more industry sectors.”
Life Science Washington Executive Committee:
- Margaret McCormick, PhD, Chair, Board of Directors – Executive Director, Chief Operating Officer, Benaroya Research Institute at Virginia Mason
- Oren Lang-Furr, Board Treasurer – Partner, EY
- Leslie Alexandre, DrPH, Board Secretary – President & CEO, Life Science Washington
- Caitlin Cameron, Chair & CEO, OtoNexus Medical Technologies
- Richard Fabian, President & COO, FUJIFILM SonoSite
- Teresa Foy, PhD, Senior Vice President, Immunology-Oncology and Cellular Therapy, Bristol-Myers Squibb
- Brad Gray, President & CEO, nanoString Technologies, Inc.
- Gustavo Mahler, PhD, Venture Partner, Dynamk Capital
- Ron Myers, MS, JD, Principal, SoundIP Consultants
- Jens U. Quistgaard, PhD, President & CEO, Taproot Medical Technologies
- Rhonda Rhyne, President & CEO, Prevencio, Inc.
- Chad Robins, CEO, Adaptive Biotechnologies
- Francisco R. Velázquez, MD, SM, Founder & Chairman, Pathos Enterprises LLC
2020 Life Science Washington Board of Directors (includes all members and the Executive Committee):
- Robin Andrulevich, Chief People Officer, Sana Biotechnology, Inc.
- Susan Ashe, Executive Director, Health Sciences & Services Authority
- Jan Beck, Head of R&D Operations, Lyell Immunopharma
- Bill Brady, President, Brady & Company
- Alice Chen, PhD, Vice President, Accelerator Life Science Partners
- Tom Clement, Principal, Clement Consulting
- John Cox, SVP-Seattle, Alexandria Real Estate Equities, Inc.
- Helga Ding, DDS, MBA, MHA, Managing Director, Kaiser Permanente Washington Health Research Institute
- Sonya F. Erickson, Partner, Cooley LLP
- W. Mike Gallatin, PhD, Senior Advisor, Frazier Healthcare Partners
- Cecilia Giachelli, PhD, Hunter and Dorothy Simpson Endowed Chair, Department of Bioengineering, University of Washington
- Jane Gross, Senior Vice President and CSO, Aptevo Therapeutics Inc.
- Lauren Hackett, MPA, Chief Operations Officer, Allen Institute
- Charlotte Hubbert, PhD, Partner, Gates Foundation Venture Capital, Bill & Melinda Gates Foundation
- Leen Kawas, PharmD & PhD, President & CEO, Athira Pharma, Inc.
- Jary J. Krauser, CEO, StratusG Consulting
- Tim Martin, Director, United States Government Affairs, Amgen
- Sean McClain, Founder & CEO, AbSci
- Claudia Mitchell, PhD, MBA, Senior VP, Product and Portfolio Strategy, Astellas
- Erik Nilsson, CEO, Deurion, LLC
- Jennifer Olsen, CEO, Resourceful HR
- Robert W. Overell, PhD, President, Foundation BioVentures
- Mitchell Parrish, JD, RAC, CIP, President, PanAmerican Clinical Research
- Craig Philips, President, Kineta, Inc.
- Ken Roberts, PhD, Vice Dean of Academic and Community Partnerships, Elson S. Floyd College of Medicine, Washington State University
- Amanda Rose, Partner, Corporate, Fenwick & West LLP
- Mike Ruhl, Vice President, Seattle Market Lead, BioMed Realty & Trust
- Lee Schindler, Partner, Perkins Coie, LLP
- Andrew T. Serafini, PhD, Partner, Kilpatrick & Townsend LLP
- Gregory Sessler, President & CEO, Olympus Respiratory America
- Ken Stuart, PhD, Professor, Seattle Children’s Research Institute
- Erik von Schenck, Vice President R&D, Physio-Control, Stryker
- John Wecker, PhD, President & CEO, Pacific Northwest Research Institute
- Nancy Whiting, PharmD, BCOP, Senior Vice President, Development and Global Medical Affairs and Elliott Bay Site Head, Seattle Genetics, Inc.
About Life Science Washington
Life Science Washington is an independent, non-profit 501(c)(6) trade association whose mission is to stimulate life science innovation, job creation and ecosystem vibrancy across Washington state through engagement, collaboration, promotion, and advocacy. Serving more than 500 members, Life Science Washington brings together research institutions, investors and innovators to grow the state’s life science economy. More information can be found at www.lifesciencewa.org.
Contacts
Sarah Healy, Life Science Washington
(206) 456-9572, sarah@lifesciencewa.org